Quantitative Systematic Strategies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-38,183
Closed -$474K 671
2020
Q3
$474K Buy
38,183
+1,592
+4% +$21.1K 0.08% 335
2020
Q2
$476K Buy
+36,591
New +$460K 0.09% 323
2020
Q1
Sell
-10,982
Closed -$172K 368
2019
Q4
$172K Buy
+10,982
New +$221K 0.03% 507

Other funds holding GOSS

Quantitative Systematic Strategies's GOSS Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Gossamer Bio (GOSS) in Q4 2020, closing a stake of 38,183 shares — an estimated $474K sold.

Quantitative Systematic Strategies first reported a position in GOSS in Q4 2019 and held it in 3 quarters. The position peaked at $476K in Q2 2020. 122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Gossamer Bio position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 38,183 Gossamer Bio shares in Q4 2020, an estimated $474K.
  • Quantitative Systematic Strategies first reported a position in Gossamer Bio in Q4 2019 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Gossamer Bio position peaked at $476K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.